Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Can liver transplantation provide the statistical cure?

Cucchetti A, Vitale A, Cescon M, Gambato M, Maroni L, Ravaioli M, Ercolani G, Burra P, Cillo U, Pinna AD.

Liver Transpl. 2014 Feb;20(2):210-7. doi: 10.1002/lt.23783. Epub 2013 Dec 12.

2.

Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.

Hung K, Gralla J, Dodge JL, Bambha KM, Dirchwolf M, Rosen HR, Biggins SW.

Liver Transpl. 2015 Nov;21(11):1365-73. doi: 10.1002/lt.24138.

3.

Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.

Baccarani U, Adani GL, Bragantini F, Londero A, Comuzzi C, Rossetto A, Lorenzin D, Bresadola V, Risaliti A, Pea F, Toniutto P, Donini A, De Anna D, Bresadola F, Tavio M, Viale P.

Transplant Proc. 2011 May;43(4):1119-22. doi: 10.1016/j.transproceed.2011.01.124.

PMID:
21620067
4.

Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients.

Avolio AW, Cillo U, Salizzoni M, De Carlis L, Colledan M, Gerunda GE, Mazzaferro V, Tisone G, Romagnoli R, Caccamo L, Rossi M, Vitale A, Cucchetti A, Lupo L, Gruttadauria S, Nicolotti N, Burra P, Gasbarrini A, Agnes S; Donor-to-Recipient Italian Liver Transplant (D2R-ILTx) Study Group..

Am J Transplant. 2011 Dec;11(12):2724-36. doi: 10.1111/j.1600-6143.2011.03732.x. Epub 2011 Sep 15.

5.

Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation.

Vitale A, Ramirez Morales R, dalla Bona E, Scopelliti M, Zanus G, Neri D, d'Amico F, Gringeri E, Russo F, Burra P, Angeli P, Cillo U.

Transplant Proc. 2011 May;43(4):974-6. doi: 10.1016/j.transproceed.2011.01.138.

PMID:
21620029
6.

Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis.

Lanini S, Nanni Costa A, Grossi PA, Procaccio F, Ricci A, Capobianchi MR, Terrault NA, Ippolito G.

Liver Int. 2016 Mar;36(3):410-7. doi: 10.1111/liv.12938. Epub 2015 Sep 21.

7.

Adult-to-adult right-lobe living donor liver transplantation in recipients with hepatitis B virus-related benign liver disease and high model end-stage liver disease scores.

Jiang L, Yan L, Tan Y, Li B, Wen T, Yang J, Zhao J.

Surg Today. 2013 Sep;43(9):1039-48. doi: 10.1007/s00595-013-0539-z. Epub 2013 Mar 7.

PMID:
23467980
8.
9.

D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.

Ikegami T, Imai D, Wang H, Yoshizumi T, Yamashita Y, Ninomiya M, Iguchi T, Bekki Y, Shirabe K, Maehara Y.

Transplantation. 2014 Feb 27;97(4):457-62. doi: 10.1097/01.TP.0000435696.23525.d0.

PMID:
24531822
10.

Who fares worse after liver transplantation? Impact of donor and recipient variables on outcome: data from a prospective study.

Gambato M, Frigo AC, Rodríguez Castro KI, Senzolo M, Nadal E, D'Amico F, Vitale A, Gringeri E, Zanus G, Cillo U, Russo FP, Burra P.

Transplantation. 2013 Jun 27;95(12):1528-34. doi: 10.1097/TP.0b013e318292827f.

PMID:
23722633
11.

Pretransplant prediction of posttransplant survival for liver recipients with benign end-stage liver diseases: a nonlinear model.

Zhang M, Yin F, Chen B, Li YP, Yan LN, Wen TF, Li B.

PLoS One. 2012;7(3):e31256. doi: 10.1371/journal.pone.0031256. Epub 2012 Mar 1.

12.

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.

Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.

Liver Transpl. 2007 May;13(5):733-40.

13.

Short and long-term outcomes after primary liver transplantation in elderly patients.

Grąt M, Kornasiewicz O, Grąt K, Antczak A, Ligocka J, Hołówko W, Wronka KM, Kobryń K, Skalski M, Pączek L, Krawczyk M.

Pol Przegl Chir. 2013 Oct;85(10):581-8. doi: 10.2478/pjs-2013-0087.

PMID:
24310761
14.

Use of hepatitis B surface antigen-positive grafts in liver transplantation: a matched analysis of the US National database.

Li Z, Hu Z, Xiang J, Zhou J, Yan S, Wu J, Zhou L, Zheng S.

Liver Transpl. 2014 Jan;20(1):35-45. doi: 10.1002/lt.23774. Epub 2013 Dec 12.

15.

Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus.

Mutimer DJ, Gunson B, Chen J, Berenguer J, Neuhaus P, Castaing D, Garcia-Valdecasas JC, Salizzoni M, Moreno GE, Mirza D.

Transplantation. 2006 Jan 15;81(1):7-14.

PMID:
16421468
16.

Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.

Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.

Liver Transpl. 2003 Jul;9(7):737-40.

17.
18.

Biliary complications adversely affect patient and graft survival after liver retransplantation.

Enestvedt CK, Malik S, Reese PP, Maskin A, Yoo PS, Fayek SA, Abt P, Olthoff KM, Shaked A.

Liver Transpl. 2013 Sep;19(9):965-72. doi: 10.1002/lt.23696. Epub 2013 Aug 18.

19.

How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?

Uemura T, Nikkel LE, Hollenbeak CS, Ramprasad V, Schaefer E, Kadry Z.

Transpl Int. 2012 Jun;25(6):671-9. doi: 10.1111/j.1432-2277.2012.01474.x. Epub 2012 Apr 6.

20.

Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.

Smits JM, Vanhaecke J, Haverich A, de Vries E, Smith M, Rutgrink E, Ramsoebhag A, Hop A, Persijn G, Laufer G.

Clin Transpl. 2003:89-100.

PMID:
15387100

Supplemental Content

Support Center